Short Interest in Odyssey Therapeutics, Inc. (NASDAQ:ODTX) Grows By ∞

Posted by Scott Moore on Jun 1st, 2026

Odyssey Therapeutics, Inc. (NASDAQ:ODTX – Get Free Report) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 86,503 shares, an increase of ∞ from the April 30th total of 0 shares. Currently, 0.2% of the company’s shares are sold short. Based on an average daily trading volume, of 426,652 shares, the days-to-cover ratio is presently 0.2 days.

Odyssey Therapeutics Stock Performance

ODTX traded down $0.05 during midday trading on Monday, reaching $16.96. The company had a trading volume of 127,382 shares, compared to its average volume of 330,139. Odyssey Therapeutics has a 1 year low of $15.35 and a 1 year high of $20.30.

Insider Transactions at Odyssey Therapeutics

In related news, major shareholder Sr One Capital Management, Llc sold 1,780 shares of Odyssey Therapeutics stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $18.00, for a total transaction of $32,040.00. Following the sale, the insider directly owned 440,981 shares in the company, valued at $7,937,658. The trade was a 0.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Tpg Gp A, Llc purchased 1,388,889 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average price of $18.00 per share, for a total transaction of $25,000,002.00. Following the completion of the transaction, the insider directly owned 3,690,146 shares of the company’s stock, valued at $66,422,628. This represents a 60.35% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last quarter, insiders purchased 4,183,777 shares of company stock worth $75,319,986.